Tesla, Inc. (TSLA) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
TSLA currently has 3.23B outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 1.16% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Oct 23, 2025 |
10-Q filing | 3227.0M shares outstanding |
3.2B | 0 |
| Apr 23, 2025 |
10-Q filing | 3218.0M shares outstanding |
3.2B | 0 |
| Jan 30, 2025 |
10-K filing | 3197.0M shares outstanding |
3.2B | 0 |
| Oct 24, 2024 |
10-Q filing | 3198.0M shares outstanding |
3.2B | 0 |
| Jul 24, 2024 |
10-Q filing | 3191.0M shares outstanding |
3.2B | 0 |
| Apr 24, 2024 |
10-Q filing | 3186.0M shares outstanding |
3.2B | 0 |
| Jan 29, 2024 |
10-K filing | 3174.0M shares outstanding |
3.2B | 0 |
| Oct 23, 2023 |
10-Q filing | 3176.0M shares outstanding |
3.2B | 0 |
| Jul 24, 2023 |
10-Q filing | 3171.0M shares outstanding |
3.2B | 0 |
| Apr 24, 2023 |
10-Q filing | 3166.0M shares outstanding |
3.2B | 0 |
| Jan 31, 2023 |
10-K filing | 3130.0M shares outstanding |
3.1B | 0 |
| Oct 24, 2022 |
10-Q filing | 3146.0M shares outstanding |
3.1B | 0 |
| Jul 25, 2022 |
10-Q filing | 1037.0M shares outstanding |
1B | 0 |
| Apr 25, 2022 |
10-Q filing | 1034.0M shares outstanding |
1B | 0 |
| Feb 07, 2022 |
10-K filing | 986.0M shares outstanding |
990M | 0 |
| Oct 25, 2021 |
10-Q filing | 998.0M shares outstanding |
1B | 0 |
| Jul 27, 2021 |
10-Q filing | 971.0M shares outstanding |
970M | 0 |
| Apr 28, 2021 |
10-Q filing | 961.0M shares outstanding |
960M | 0 |
| Feb 08, 2021 |
10-K filing | 933.0M shares outstanding |
930M | 0 |
| Oct 26, 2020 |
10-Q filing | 937.0M shares outstanding |
940M | 0 |
| Jul 28, 2020 |
10-Q filing | 186.0M shares outstanding |
190M | 0 |
| Apr 30, 2020 |
10-Q filing | 183.0M shares outstanding |
180M | 0 |
| Feb 19, 2020 |
8-K filing: Tesla, Inc. completed a public offering of 2,650,000 shares of common stock, with an additional 397,500 shares sold through the Underwriters' option, resulting in net proceeds of approximately $2.31 billion. ($2310.0M proceeds) |
180M | 0 |
| Feb 13, 2020 |
10-K filing | 177.0M shares outstanding |
180M | 0 |